ÇÒÀιæ
Clinics- Àú³Î ´ÜÇົ
µðÁöÅÐ, ÀΰøÁö´ÉÀÇÇÐ
µ¿¹°º¸°Ç»ç
Çѱ۵µ¼­ ±âÃÊ
Çѱ۵µ¼­ ³»°ú
Çѱ۵µ¼­ ¿Ü°ú
Çѱ۵µ¼­ ¿µ»ó/¾È°ú/Ä¡°ú
Çѱ۵µ¼­ ±âŸ
±âÃÊ »ý¸íÀÇ°úÇÐ
½ÇÇ赿¹°
¼öÀÇ À±¸®/º¹Áö
±â»ýÃæ/»ê°ú/À¯Àü
°øÁߺ¸°Ç/Àü¿°º´ÇÐ
µ¶¼º/¾à¸®,¾àÀü
¸é¿ª/¹Ì»ý¹°ÇÐ
¹ß»ý/ÇغÎ/»ý¸®ÇÐ
Á¶Á÷/º´¸®ÇÐ
¼ö»ýµ¿¹°
Á¶·ù
»ê¾÷/Áß,´ëµ¿¹°
µÅÁö
¸»
¼Ò
°í¾çÀÌ
µ¿¹° º¸Á¤,Çڵ鸵
¼öÀÇ ÀϹÝ/±âŸ Âü°íµµ¼­
¼Òµ¿¹° ³»°ú
¼Òµ¿¹° ¿Ü°ú
ÀçÈ°/½Å°æ, Á¤Çü¿Ü°úÇÐ
³»½Ã°æ, ÀÚ·É/³ë·Éµ¿¹°ÇÐ
ºñ´¢±â/À̺ñÀÎÈÄ°ú
¸¶Ãë,ÅëÁõ/ÀÀ±Þ,¼ö¾×
¼ÒÈ­/¿µ¾ç/ÇǺÎÇÐ
³»ºÐºñ/½Å°æ/ÇൿÇÐ
½ÉÀå,È£Èí±â/Á¾¾çÇÐ
¾È°ú/Ä¡°úÇÐ
¿µ»óÁø´ÜÀÇÇÐ
ÀÓ»óº´¸®(¼¼Æ÷,Ç÷¾×ÇÐ)
´ëüÀÇÇÐ(ħ¼ú,Çãºê)
¾ß»ý/Ư¼öµ¿¹° Exo, Zoo
Á¾º¸Á¸/µ¿¹°º¸È£/¹ýÀÇÇÐ
º´¿ø°æ¿µ/»çÀü/¿ë¾î
BSAVA ½Ã¸®Áî
ÀÚÀ¯°áÁ¦
100ÀÚ ¼­Æò
Áú¹®°ú ´ë´ä
  T: 042-330-0039

  042-361-2500

  HP: 010-8364-0400

  F: 042-367-1017

ÆòÀÏ 10:00 ~ 18:00


À̸ÞÀϹ®ÀÇ
½ÅÇÑ 100-023-144280
±¹¹Î 732801-01-097961
³óÇù 453131-56-197831
Çϳª 660-910336-13307
¿¹±ÝÁÖ: ÀÌ»óµ· okvet
 
 
ºñ¹Ð¹øÈ£ È®ÀÎ ´Ý±â
¼öÀÇ À±¸®/º¹Áö > BioIndustry Ethics

 
BioIndustry Ethics
»óÇ°¸í : BioIndustry Ethics
Á¦Á¶È¸»ç : Academic Press
¿ø»êÁö : USA
Àû¸³±Ý¾× : 2,190¿ø
¼ÒºñÀÚ°¡ : 73,000¿ø
ÆǸŰ¡°Ý : 73,000¿ø
¼ö·® EA
 
¹è¼ÛÁ¶°Ç : (Á¶°Ç)
   
 
 
BioIndustry Ethics
 
David Finegold
Strategy & Organization Studies, Keck Graduate Institute for the Applied Life Sciences
Cecile Bensimon
University of Toronto Joint Centre for Bioethics
Abdallah Daar
University of Toronto Joint Centre for Bioethics
Margaret Eaton
Stanford University Center for Biomedical Ethics
Beatrice Godard
Facult?de m?ecine, Universit?de Montr?l
Bartha Knoppers
Facult?de droit, Universit?de Montr?l
Jocelyn Mackie
University of Toronto Joint Centre for Bioethics
Peter Singer
University of Toronto Joint Centre for Bioethics

ISBN: 9780123693709
ISBN10: 0123693705       
Book/Paperback
Measurements: 6 X 9 in
Pages: 384
Imprint: Academic Press
Publication Date: 10 June 2005


Reviews


"Biotechnology and pharmaceutical companies are often driven by profit goals, but the case studies in Bioindustry Ethics show that this is increasingly not at the expense of ethical integrity. ...lend[s] important insights to other executives and professionals who might be developing their own practices and policies."
- GENOMICS & PROTEOMICS (August 2005)

Description

 


This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Contents

 back to top


Preface
Introduction
Leadership
Starting Right
Ethics in an Emerging Field
Getting Advice
Self-Assessment
Endnotes

 
 
 
 
»óÈ£¸í : OKVET »ç¾÷ÀÚµî·Ï¹øÈ£ : 314-90-93001 314-90-93001 Åë½ÅÆǸž÷½Å°í¹øÈ£ : À¯¼º±¸Ã» Á¦2006-75È£
[ÀÌ¿ë¾à°ü] [°³ÀÎÁ¤º¸ 󸮹æħ] °³ÀÎÁ¤º¸ º¸È£ Ã¥ÀÓÀÚ : ÀÌ»óµ· ´ëÇ¥ : ÀÌ»óµ·
»ç¾÷Àå¼ÒÀçÁö : ´ëÀü±¤¿ª½Ã À¯¼º±¸ Å×Å©³ë3·Î 65, ÇѽŠS-MECA 440È£
Copyright ¨Ï okvet All Rights Reserved. T: 042-330-0039, 042-361-2500, HP: 010-8364-0400, F: 042-367-1017